Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-01-03 @ 2:40 PM
Study NCT ID:
NCT02450656
Status:
UNKNOWN
Last Update Posted:
2018-08-27
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2019-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-12
Completion Date Type:
ESTIMATED
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2015-05-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-24
Last Update Post Date:
2018-08-27
Last Update Post Date Type:
ACTUAL